Welcome to our dedicated page for COVAU news (Ticker: COVAU), a resource for investors and traders seeking the latest updates and insights on COVAU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect COVAU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of COVAU's position in the market.
COVA Acquisition Corp. (NASDAQ: COVAU) announced it received a notice from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to the late filing of its Q1 2021 Form 10-Q. The filing was delayed beyond the original due date of May 17, 2021, and the extension of May 24, 2021. The Company submitted the report on June 1, 2021, which is expected to restore compliance. The notice does not impact the trading of COVAU's securities on Nasdaq. Future results remain uncertain as outlined in the cautionary statements regarding forward-looking information.
COVA Acquisition Corp. (Nasdaq: COVAU) completed its initial public offering, raising $300 million by selling 30 million units at $10.00 each, which included an additional 3.9 million units from the underwriter's over-allotment option. The units began trading on Nasdaq on February 5, 2021. Each unit includes one Class A ordinary share and a half warrant for purchasing ordinary shares at $11.50. The firm aims to target high-growth tech businesses in Southeast Asia but may consider various sectors.
COVA Acquisition Corp. announced the pricing of its initial public offering (IPO) at $10.00 per unit, with a total of 26,100,000 units offered. An additional 3,915,000 units are available for underwriters to cover over-allotments. The IPO is scheduled to begin trading on February 5, 2021, under the ticker symbol 'COVAU.' Each unit includes one Class A ordinary share and one-half of a redeemable warrant, with warrants exercisable at $11.50 per share. COVA aims to merge or acquire technology-focused businesses in Southeast Asia, backed by Crescent Cove Advisors LP.
